Healthcare

Anixa Biosciences is intensifying its strategic focus on a pair of clinical-stage oncology assets. In a recent update, the company’s...

Talphera has achieved a significant enrollment milestone for its lead investigational drug, Niyad. The company announced that patient recruitment for...

The medical technology firm Carl Zeiss Meditec is navigating a perfect storm of challenges. A combination of collapsing profitability, a...

Recent developments at Anixa Biosciences point to significant progress across its oncology pipeline. The company's latest annual shareholder meeting served...

The medical technology giant Siemens Healthineers is navigating a period of significant transition. As its parent company, Siemens AG, moves...

At the upcoming HIMSS 2026 conference in Las Vegas, Wolters Kluwer is set to showcase its latest artificial intelligence-driven solutions...

A major legal overhang for the telehealth company Hims & Hers has been decisively removed, sending its shares skyrocketing. The...

Investor attention within the biotechnology space is increasingly focused on Outlook Therapeutics. The company is approaching several pivotal operational milestones...

The medical technology firm Strata Skin Sciences is moving to formally terminate its status as a publicly traded company. This...

Following the full integration of Progressive Care, NextPlat Corp. is expressing confidence in its operational trajectory for the coming periods....